Construction of a universal model for non-invasive identification of cephalosporins for injection using near-infrared diffuse reflectance spectroscopy

Vibrational Spectroscopy

Volumn 49, Issue 2, 2009, Pages 196-203

  Chong, Xiao Meng ^a   Hu, Chang Qin ^a   Feng, Yan Chun ^a   Pang, Huan Huan ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Cephalosporin for injection; Classification model; NIR diffuse reflectance spectroscopy

Indexed keywords

DRUG PRODUCTS; INFRARED DEVICES; REFLECTION; SEWAGE TREATMENT PLANTS; SPECTRUM ANALYSIS;

CEPHALOSPORIN FOR INJECTION; CLASSIFICATION MODEL; COUNTERFEIT DRUGS; DISTRIBUTION CHANNELS; NEAR INFRA REDS; NIR DIFFUSE REFLECTANCE SPECTROSCOPY; NON-INVASIVE; OPEN MARKETS; PRINCIPLE COMPONENT ANALYSIS; UNIVERSAL MODELS;

INFRARED SPECTROSCOPY;

EID: 60249102482     PISSN: 09242031     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vibspec.2008.07.010     Document Type: Article

References (16)

1. World Health Organization. Combating counterfeit drugs: a concept paper for effective international cooperation, 2006 (27.01.06) http://www.who.int/medicines/services/counterfeit/en/index.html.
2. Tomlinson R. BMJ 318 (1999) 624
3. Mukhopadhyay R. Anal. Chem. 1 April (2007) 2623
4. Scafi S.H.F., and Pasquini C. Analyst 126 (2001) 2218
5. Olsen B.A., Borer M.W., Perry F.M., and Forbes R.A. Pharm. Technol. 6 (2002) 62
6. Rodionova O.Y., Houmøller L.P., Pomerantsev A.L., Geladi P., Dorofeyev B.V.L., and Arzamastsev A.P. ACA 549 (2005) 151
7. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., and de Kaste D. J. Pharm. Biomed. Anal. 40 (2006) 840
8. Blanco M., and Romero M.A. Analyst 126 (2001) 2212
9. Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., and Jent N. J. Pharm. Biomed. Anal. 44 (2007) 683
10. Luypaert J., Massart D.L., and Vander-Heyden Y. Talanta 72 (2007) 865
11. Broad N.W., Jee R.D., Moffat A.C., Eaves M.J., Mann W.C., and Dziki W. Analyst 125 (2000) 2054
12. Ufret C., and Morris K. Drug Dev. Ind. Pharm. 27 (2001) 719
13. Herkert T., Prinz H., and Kovar K. Eur. J. Pharm. Biopharm. 51 (2001) 9
14. Blanco M., Eustaquio A., González J.M., and Serrano D. J. Pharm. Biomed. Anal. 22 (2000) 139
15. Laasonen M., Harmia-Pulkkinen T., Simard C., Räsänen M., and Vuorela H. Anal. Chem. 75 (2003) 754
16. Feng Y.C., and Hu C.Q. J. Pharm. Biomed. Anal. 41 (2006) 373